EGR1 Decreases the Malignancy of Human Non-small Cell Lung Carcinoma by Regulating KRT18 Expression

Overview

Journal Sci Rep

Specialty Science

Date 2014 Jul 4

PMID 24990820

Citations 47

Authors

Huihua Zhang

Xiaojia Chen

Jiakang Wang

Wenhua Guang

Wei Han

Hang Zhang

Xuan Tan

Yong Gu

Affiliations

Soon will be listed here.

Abstract

Early growth response 1 (EGR1) is a multifunctional transcription factor; Positive and negative functions of EGR1 in various tumors rely on the integrated functions of various genes it regulates. In this study, we observed the role of EGR1 in non-small-cell lung carcinoma (NSCLC) and identified genes that influence cell fate and tumor development. Various assays showed that EGR1 arrested cell mobility, inhibited migration, and induced apoptosis. Microarray analysis revealed that 100 genes, including CDKN1C, CDC27 and PRKDC, changed their mRNA expressions with the increase of EGR1 and contributed to intervention of tumor progression. Bioinformatics analysis and promoter analysis indicated that an EGR1 binding site was situated in the promoter of KRT18 (also named CK18) and KRT18 could assist in inhibition of NSCLC development. The expression level of EGR1 and KRT18 in NSCLC clinical cases was investigated by immunohistochemistry, in which the protein expression of KRT18 was found to be significantly associated with EGR1 and lymph node metastasis. The results collectively confirm that EGR1 functions as a tumor suppressor in NSCLC. This study is the first to report KRT18 expression is directly regulated by EGR1, and contributes to decrease malignancy of NSCLC.

Citing Articles

HCG18 Promotes Cell Proliferation and Stemness in Cholangiocarcinoma via the miR-194-5p/KRT18/MAPK Signaling.

Tian G, Zuo L, Li J, Zheng X, Gao F Biochem Genet. 2025; .

PMID: 39776371 DOI: 10.1007/s10528-025-11020-7.

Cis-Regulation of an mA Eraser by an Insertion Variant Associated with Survival of Patients With Non-Small Cell Lung Carcinoma.

Cheng L, Hu Q, Wang Y, Nie W, Lu H, Zhang B Adv Sci (Weinh). 2024; 12(5):e2407652.

PMID: 39680684 PMC: 11791940. DOI: 10.1002/advs.202407652.

The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis.

Yan J, Yang A, Tu S Front Oncol. 2024; 14:1445978.

PMID: 39502314 PMC: 11534658. DOI: 10.3389/fonc.2024.1445978.

Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade.

Jagodinsky J, Vera J, Jin W, Shea A, Clark P, Sriramaneni R Sci Transl Med. 2024; 16(765):eadk0642.

PMID: 39292804 PMC: 11522033. DOI: 10.1126/scitranslmed.adk0642.

Decoding temporal heterogeneity in NSCLC through machine learning and prognostic model construction.

Cheng J, Xiao M, Meng Q, Zhang M, Zhang D, Liu L World J Surg Oncol. 2024; 22(1):156.

PMID: 38872167 PMC: 11170806. DOI: 10.1186/s12957-024-03435-0.

References

Ferraro B, Bepler G, Sharma S, Cantor A, Haura E . EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer. J Clin Oncol. 2005; 23(9):1921-6. DOI: 10.1200/JCO.2005.08.127. View

Adamson E, Mercola D . Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival. Tumour Biol. 2002; 23(2):93-102. DOI: 10.1159/000059711. View

Baron V, Adamson E, Calogero A, Ragona G, Mercola D . The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther. 2005; 13(2):115-24. PMC: 2455793. DOI: 10.1038/sj.cgt.7700896. View

Monsalve F, Valderrama J, Vasquez D, Ibacache A, Rodriguez J, Gonzalez D . Inhibition of human topoisomerase I and activation of caspase-3 by aza-angucyclinones and arylaminopyrimido[4,5-c]isoquinoline-7,10-quinones. Int J Mol Med. 2012; 30(1):151-6. DOI: 10.3892/ijmm.2012.961. View

Huang R, Liu C, Fan Y, Mercola D, Adamson E . Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res. 1995; 55(21):5054-62. View

Sakaue M, Adachi H, Jetten A . Post-transcriptional regulation of MyD118 and GADD45 in human lung carcinoma cells during 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2- naphthalene carboxylic acid-induced apoptosis. Mol Pharmacol. 1999; 55(4):668-76. View

Weng Y, Cui Y, Fang J . Biological functions of cytokeratin 18 in cancer. Mol Cancer Res. 2012; 10(4):485-93. DOI: 10.1158/1541-7786.MCR-11-0222. View

Xu X, Wang W, Zhang L, Li Y, Tang M, Jiang N . Clinical implications of p57 KIP2 expression in breast cancer. Asian Pac J Cancer Prev. 2012; 13(10):5033-6. DOI: 10.7314/apjcp.2012.13.10.5033. View

Matsuoka S, Edwards M, Bai C, Parker S, Zhang P, Baldini A . p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995; 9(6):650-62. DOI: 10.1101/gad.9.6.650. View

10.

Levkovitz Y, Baraban J . A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation. J Neurosci. 2001; 21(16):5893-901. PMC: 6763154. View

11.

Okazawa S, Furusawa Y, Kariya A, Hassan M, Arai M, Hayashi R . Inactivation of DNA-dependent protein kinase promotes heat-induced apoptosis independently of heat-shock protein induction in human cancer cell lines. PLoS One. 2013; 8(3):e58325. PMC: 3594312. DOI: 10.1371/journal.pone.0058325. View

12.

Whitmarsh A, Shore P, Sharrocks A, Davis R . Integration of MAP kinase signal transduction pathways at the serum response element. Science. 1995; 269(5222):403-7. DOI: 10.1126/science.7618106. View

13.

Yilmaz Y . Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. Aliment Pharmacol Ther. 2009; 30(11-12):1103-9. DOI: 10.1111/j.1365-2036.2009.04148.x. View

14.

Boone D, Qi Y, Li Z, Hann S . Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism. Proc Natl Acad Sci U S A. 2010; 108(2):632-7. PMC: 3021028. DOI: 10.1073/pnas.1008848108. View

15.

Fortier A, Asselin E, Cadrin M . Keratin 8 and 18 loss in epithelial cancer cells increases collective cell migration and cisplatin sensitivity through claudin1 up-regulation. J Biol Chem. 2013; 288(16):11555-71. PMC: 3630871. DOI: 10.1074/jbc.M112.428920. View

16.

Lv H, Liu L, Zhang Y, Song T, Lu J, Chen X . Ingenuity pathways analysis of urine metabonomics phenotypes toxicity of gentamicin in multiple organs. Mol Biosyst. 2010; 6(10):2056-67. DOI: 10.1039/c0mb00064g. View

17.

Takekawa M, Saito H . A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell. 1998; 95(4):521-30. DOI: 10.1016/s0092-8674(00)81619-0. View

18.

Thiel G, Cibelli G . Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol. 2002; 193(3):287-92. DOI: 10.1002/jcp.10178. View

19.

Potikha T, Kassem S, Haber E, Ariel I, Glaser B . p57Kip2 (cdkn1c): sequence, splice variants and unique temporal and spatial expression pattern in the rat pancreas. Lab Invest. 2005; 85(3):364-75. DOI: 10.1038/labinvest.3700229. View

20.

Gregg J, Fraizer G . Transcriptional Regulation of EGR1 by EGF and the ERK Signaling Pathway in Prostate Cancer Cells. Genes Cancer. 2012; 2(9):900-9. PMC: 3352154. DOI: 10.1177/1947601911431885. View